DDInter1606 DDInter1376
Adrenergic beta-agonist used to control premature labor.
Ozanimod is a once-daily sphingosine 1-phosphate receptor modulator for the treatment of relapsing Multiple Sclerosis (MS) and inflammatory bowel disease. It was developed by Celgene (now acquired by Bristol-Myers Squibb) and was approved by the FDA on March 26, 2020.[L12573,L12582] The US approval was followed by the approval in Canada on October 2, 2020. In November 2021, ozanimod was also approved by the European Commission for the treatment of adults with relapsing remitting multiple sclerosis.[L39377,L39382] MS is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. Inflammatory bowel disease also a chronic inflammatory condition and can cause persistent abdominal pain, diarrhea, bloody stools, and vomiting. In clinical trials, Ozanimod has been shown to be well-tolerated and has resulted in a higher decrease in the rate of MS relapses than with intramuscular [interferon beta-1a], a current standard in MS therapy. Studies involving patients with inflammatory bowel disease have also shown promising results.[A189318,A189342]
Ritodrine {u} (Compound) resembles {v} (Compound) Arformoterol
Ritodrine {u} (Compound) resembles {v} (Compound) Dobutamine
Ritodrine {u} (Compound) binds {v} (Gene) GALR3
Ritodrine {u} (Compound) upregulates {v} (Gene) TGFBR2
Ritodrine {u} (Compound) downregulates {v} (Gene) POLR2I
Ritodrine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Flunisolide
Ritodrine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Ciclesonide
Ritodrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Isoprenaline
Ritodrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Phenylpropanolamine
Ritodrine {u} may lead to a major life threatening interaction when taken with {v} Ivosidenib
Ritodrine (Compound) resembles Arformoterol (Compound)
Ritodrine (Compound) resembles Dobutamine (Compound)
Ritodrine (Compound) binds GALR3 (Gene)
Ritodrine (Compound) upregulates TGFBR2 (Gene)
Ritodrine (Compound) downregulates POLR2I (Gene)
Ritodrine may cause a minor interaction that can limit clinical effects when taken with Flunisolide
Ritodrine may cause a minor interaction that can limit clinical effects when taken with Ciclesonide
Ritodrine may cause a moderate interaction that could exacerbate diseases when taken with Isoprenaline
Ritodrine may cause a moderate interaction that could exacerbate diseases when taken with Phenylpropanolamine
Ritodrine may lead to a major life threatening interaction when taken with Ivosidenib